Ashley E Ross

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi request reprint Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program
    Ashley E Ross
    Departments of Urology and Pathology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD, USA
    J Clin Oncol 28:2810-6. 2010
  2. doi request reprint Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland
    Prostate 73:1673-80. 2013
  3. doi request reprint Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer
    Ashley E Ross
    James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medicinal Institutions, Baltimore, MD, USA
    BJU Int 110:651-7. 2012
  4. pmc Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA
    BJU Int 112:45-53. 2013
  5. pmc African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
    Debasish Sundi
    Johns Hopkins University, Baltimore, MD, USA
    J Clin Oncol 31:2991-7. 2013
  6. pmc Wnt signaling though beta-catenin is required for prostate lineage specification
    Brian W Simons
    Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Dev Biol 371:246-55. 2012
  7. pmc Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
    Paula J Hurley
    Department of Urology, The Johns Hopkins University, Baltimore, MD 21231, USA
    Proc Natl Acad Sci U S A 109:14977-82. 2012
  8. doi request reprint Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 110:1122-8. 2012
  9. pmc Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer
    Phillip M Pierorazio
    Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 109:988-93. 2012
  10. pmc Sox9 is required for prostate development and prostate cancer initiation
    Zhenhua Huang
    Department of Urology, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Oncotarget 3:651-63. 2012

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program
    Ashley E Ross
    Departments of Urology and Pathology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD, USA
    J Clin Oncol 28:2810-6. 2010
    ....
  2. doi request reprint Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland
    Prostate 73:1673-80. 2013
    ..We report the 30-year institutional experience of radical prostatectomy (RP) for men with clinically localized prostate cancer (PC) found to have lymph node (LN) metastases at surgery...
  3. doi request reprint Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer
    Ashley E Ross
    James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medicinal Institutions, Baltimore, MD, USA
    BJU Int 110:651-7. 2012
    ....
  4. pmc Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA
    BJU Int 112:45-53. 2013
    ..Specifically, it addresses approach-specific morbidities and indicates that MIRP is associated with higher rates of 'off-pathway' discharge, most often due to ileus...
  5. pmc African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
    Debasish Sundi
    Johns Hopkins University, Baltimore, MD, USA
    J Clin Oncol 31:2991-7. 2013
    ..To explore whether race-based health disparities exist among men with very low-risk PCa, we evaluated oncologic outcomes of AA men with very low-risk PCa who were candidates for AS but elected to undergo radical prostatectomy (RP)...
  6. pmc Wnt signaling though beta-catenin is required for prostate lineage specification
    Brian W Simons
    Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Dev Biol 371:246-55. 2012
    ..Deletion of beta-catenin in the adult prostate did not significantly affect organ homeostasis. Collectively, these data establish that beta-catenin and Wnt signaling play key roles in prostate lineage specification and bud outgrowth...
  7. pmc Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
    Paula J Hurley
    Department of Urology, The Johns Hopkins University, Baltimore, MD 21231, USA
    Proc Natl Acad Sci U S A 109:14977-82. 2012
    ..Thus, SPARCL1 is a potent regulator of cell migration/invasion and its loss is independently associated with prostate cancer recurrence...
  8. doi request reprint Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 110:1122-8. 2012
    ....
  9. pmc Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer
    Phillip M Pierorazio
    Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 109:988-93. 2012
    ....
  10. pmc Sox9 is required for prostate development and prostate cancer initiation
    Zhenhua Huang
    Department of Urology, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Oncotarget 3:651-63. 2012
    ..Due to its essential role in cancer initiation, manipulation of Sox9 targets in at-risk men may prove useful in the chemoprevention of prostate cancer...
  11. pmc Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity
    Ashley E Ross
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    BJU Int 108:447-54. 2011
    ..To evaluate the cytotoxicity of dimeric naphthoquinones (BiQs) in prostate cancer cells. • To assess the interaction of dimeric naphthoquinones with common therapies including radiation and docetaxel...
  12. doi request reprint A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 185:1691-7. 2011
    ..We investigated outcomes in men with pT3b disease in the contemporary era...
  13. pmc Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cells
    Ashkan Emadi
    Johns Hopkins University, School of Medicine, Department of Internal Medicine, Division of Hematology, 720 Rutland Avenue, Baltimore, MD 21205, USA
    Bioorg Med Chem 19:7057-62. 2011
    ..These results also suggest that dimeric naphthoquinones may be used to selectively target cancer cells that depend on oxidative phosphorylation for energy production and macromolecular synthesis...
  14. pmc Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice
    Trinity J Bivalacqua
    James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 76:510.e7-12. 2010
    ..Therefore, the objective of the present study was to evaluate the molecular changes in RhoA and ROCK in an established transgenic sickle cell mouse model of priapism...
  15. ncbi request reprint Benign prostate glands at the bladder neck margin in robotic vs open radical prostatectomy
    Stacy Loeb
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    BJU Int 105:1446-9. 2010
    ....
  16. doi request reprint Molecular effects of genistein on male urethral development
    Ashley E Ross
    Department of Urology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    J Urol 185:1894-8. 2011
    ..We investigated the effects of genistein, the primary phytoestrogen in soy, on the molecular program of male urethral development...
  17. pmc Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk
    Theresa Tretter
    Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    J Exp Med 198:1863-73. 2003
    ..Thus, sustained activation of Blk induces responses normally associated with the pre-BCR...
  18. pmc Posttranslational modification of constitutive nitric oxide synthase in the penis
    Biljana Musicki
    The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins Medical Institutions, 600 N Wolfe Avenue, Marburg 143, Baltimore, MD 21287, USA
    J Androl 30:352-62. 2009
    ..This communication reviews the role of eNOS and nNOS in erectile physiology and discusses the alterations in eNOS and nNOS via posttranslation modification in various vascular diseases of the penis...